AMOÉBA Confirms Development Potential in Cosmetics Sector

AMOÉBA, a greentech company based in Chassieu, France, has announced positive results from a clinical study involving its cosmetic ingredient. Conducted by the Institut d'Expertise Clinique, the study involved 30 volunteers and verified significant improvements in skin care attributes, including dermis thickness, dermal texture, and skin density.

This follows an earlier announcement in October 2023, where tests on artificial skin showed promising outcomes, prompting AMOÉBA to explore cosmetic applications further. The company's active ingredient has now been included on the International Nomenclature for Cosmetic Ingredients (INCI) list, facilitating market entry without additional regulatory approvals.

AMOÉBA will present its strategy at the Portzamparc BNP Paribas Group Conference in Paris on June 12. The presentation will be available on the company’s website by June 11.